ZA925515B - A process for the preparation of demethylepypodophyllotoxin - Google Patents

A process for the preparation of demethylepypodophyllotoxin

Info

Publication number
ZA925515B
ZA925515B ZA925515A ZA925515A ZA925515B ZA 925515 B ZA925515 B ZA 925515B ZA 925515 A ZA925515 A ZA 925515A ZA 925515 A ZA925515 A ZA 925515A ZA 925515 B ZA925515 B ZA 925515B
Authority
ZA
South Africa
Prior art keywords
demethylepipodophyllotoxin
beta
alkylidene
react
ester
Prior art date
Application number
ZA925515A
Other languages
English (en)
Inventor
Pietro Allevi
Allevi Pietro
Mario Anastasia
Anastasia Mario
Ettore Bigatti
Bigatti Ettore
Peter Macdonald
Macdonald Peter
Original Assignee
Sicor Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11360401&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA925515(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sicor Spa filed Critical Sicor Spa
Publication of ZA925515B publication Critical patent/ZA925515B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA925515A 1991-07-23 1992-07-22 A process for the preparation of demethylepypodophyllotoxin ZA925515B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912025A IT1250692B (it) 1991-07-23 1991-07-23 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.

Publications (1)

Publication Number Publication Date
ZA925515B true ZA925515B (en) 1993-04-28

Family

ID=11360401

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925515A ZA925515B (en) 1991-07-23 1992-07-22 A process for the preparation of demethylepypodophyllotoxin

Country Status (16)

Country Link
US (1) US5688925A (ja)
EP (1) EP0595888B1 (ja)
JP (1) JP3231765B2 (ja)
AT (1) ATE159026T1 (ja)
AU (1) AU666322B2 (ja)
CA (1) CA2113894C (ja)
DE (1) DE69222643T2 (ja)
DK (1) DK0595888T3 (ja)
ES (1) ES2107546T3 (ja)
FI (1) FI110782B (ja)
GR (1) GR3025729T3 (ja)
IL (1) IL102610A (ja)
IT (1) IT1250692B (ja)
MX (1) MX9204334A (ja)
WO (1) WO1993002094A1 (ja)
ZA (1) ZA925515B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL119749A (en) * 1995-12-04 2001-03-19 Nippon Kayaku Kk Process for producing etoposide
KR100519498B1 (ko) * 1997-06-02 2005-10-07 브리스톨-마이어즈 스퀴브 컴페니 에토포사이드의 제조방법
AU5612399A (en) 1998-09-10 2000-04-03 Phytogen Life Sciences Inc. Synthetic method for the preparation of the antineoplastic agent etoposide
FR2791681B1 (fr) * 1999-03-29 2001-06-22 Pf Medicament Nouveau procede de preparation de l'etoposide
GB0019124D0 (en) * 2000-08-03 2000-09-27 Pfizer Novel process
CN101146532B (zh) 2005-01-21 2012-05-09 阿斯泰克斯治疗有限公司 药物化合物
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
EP4176871A1 (en) 2011-10-03 2023-05-10 Canqura Oncology Ab Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
AR095962A1 (es) 2013-04-01 2015-11-25 Moreinx Ab Nanopartículas, compuestas de esterol y saponina de quillaja saponaria molina, proceso para preparación y uso de las mismas como portadores para moléculas anfipáticas o hidrófobas en el campo de la medicina incluyendo tratamiento de cáncer y compuestos relacionados con alimentos
EP3616688A1 (en) 2018-08-27 2020-03-04 Centre National de la Recherche Scientifique - CNRS Preparation of nanosuspension comprising nanocrystals of active pharmaceutical ingredients with little or no stabilizing agents
EP3669890A1 (en) 2018-12-18 2020-06-24 Croda International PLC Filamentous nanoparticles having vaccine adjuvant effect
CN113121618A (zh) * 2021-04-07 2021-07-16 梯尔希（南京）药物研发有限公司 两种依托泊苷杂质的制备方法
CN115197281A (zh) * 2021-04-09 2022-10-18 四川汇宇制药股份有限公司 依托泊苷中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
DK39886D0 (da) * 1986-01-27 1986-01-27 Hans Goeran Magnusson Hydroxybeskyttelsesgrupper
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
DE3935016A1 (de) * 1989-10-20 1991-04-25 Behringwerke Ag Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten
FR2658824B1 (fr) * 1990-02-27 1992-07-03 Pf Medicament Tris acetyl-2",3",4' ethylidene-4",6" beta-d-glucopyranosides, leur preparation et leur utilisation pour la preparation d'ethylidene beta-d-glucopyranoside de demethyl-4' epipodophyllotoxine.
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
CN1025918C (zh) * 1990-06-07 1994-09-14 国家医药管理局上海医药工业研究院 抗肿瘤药表鬼臼毒吡喃糖甙的合成新工艺

Also Published As

Publication number Publication date
ATE159026T1 (de) 1997-10-15
IL102610A (en) 1997-03-18
WO1993002094A1 (en) 1993-02-04
IT1250692B (it) 1995-04-21
GR3025729T3 (en) 1998-03-31
DE69222643D1 (de) 1997-11-13
JP3231765B2 (ja) 2001-11-26
AU666322B2 (en) 1996-02-08
FI940280A (fi) 1994-01-20
JPH06509334A (ja) 1994-10-20
CA2113894A1 (en) 1993-02-04
EP0595888A1 (en) 1994-05-11
MX9204334A (es) 1993-02-01
DK0595888T3 (da) 1998-05-18
AU2326592A (en) 1993-02-23
CA2113894C (en) 2003-12-16
DE69222643T2 (de) 1998-02-05
FI110782B (fi) 2003-03-31
FI940280A0 (fi) 1994-01-20
ITMI912025A1 (it) 1993-01-24
ITMI912025A0 (it) 1991-07-23
US5688925A (en) 1997-11-18
ES2107546T3 (es) 1997-12-01
EP0595888B1 (en) 1997-10-08

Similar Documents

Publication Publication Date Title
ZA925515B (en) A process for the preparation of demethylepypodophyllotoxin
HUT60328A (en) Process for producing ethanol with transformed microorganisms
CA2044619A1 (en) Preparation method for .alpha.,.beta.-unsaturated ketones
MX9704765A (es) Mejoras en o que se relacionan con la funcion endometrial.
EP0327099A3 (en) Cyclomaltodextrin glucanotransferase, process for its preparation and novel microorganism useful for the process
IE850912L (en) 9a-AZA-9a HOMOERYTHROMYCIN DERIVATIVES.
DE69032797T2 (de) Avermectin-Derivate
AU628546B2 (en) Energy meter
Maegawa Ecological studies of Eisenia bicyclis (Kjellman) Setchell and Ecklonia cava kjellman
AU4782790A (en) Novel tetralin derivatives
ZA883762B (en) Novel 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives
EP0246646A3 (en) Process for the preparation of 4-acetals of 1,4-butene dial, and acetals of 1,4-butene dial
EP0333653A3 (en) Reactive dyes, process for their preparation and their use
IL93592A0 (en) Mammalian cell line and its use for detecting certain molecules
EP0212867A3 (en) Antihelmintic avermectin derivatives produced by the fermentation of a microorganism
PL292898A1 (en) Method of obtaining novel monomer of 3-rd order butoxycarbonyl-l-thyrosipeptide glicane and its derivative labelled with 125 j
AU631935B2 (en) Triphenodioxane reactive dyes
IE883358L (en) Ethylated avermectins
GB2233666B (en) Microbacterium strain 851, culture media for same and production of single cell nutrient solution.
DE3160133D1 (en) 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines, process for their preparation and pharmaceutical compositions containing them
GB8620785D0 (en) Microorganism culture & testing
Stosic et al. Effect of photoperiod on the calcium uptake by microsomes and mitochondria from green leaves
EP0257276A3 (en) Process for producing antibiotic ll-42067alpha
GB8819758D0 (en) Production of 2-methyl-5-isopropyl-hexa-2,5-dien-1-al & of 2-methyl-5-isopropyl-hexa-2,4-dien-1-al in microorganisms
JPS57126499A (en) 4'-deoxymycaminosyl tylonoline derivative